Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Enpro Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Enpro Inc. April 29, 202699.6%
-
NewAmsterdam Pharma Company N.V. June 4, 202599.8%
-
Tyra Biosciences Inc. May 29, 2025100.0%
-
Enpro Inc. April 30, 202599.6%
-
Enpro Inc. May 2, 202498.3%
-
Enpro Inc. April 28, 202397.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Enpro Inc. | Grant or award | +567 | $246.91 | $139,998 |
| Jan 7, 2026 | NewAmsterdam Pharma Company N.V. | Grant or award | +3,400 | — | — |
| Apr 15, 2025 | NewAmsterdam Pharma Company N.V. | Grant or award | +10,860 | — | — |
| Feb 15, 2024 | Enpro Inc. | Grant or award | +803 | $155.66 | $124,995 |
| Feb 16, 2023 | Enpro Inc. | Grant or award | +942 | $116.69 | $109,922 |
Questions about Adele M. Gulfo
What boards is Adele M. Gulfo on?
Adele M. Gulfo sits on the boards of Enpro Inc., NewAmsterdam Pharma Company N.V. and Tyra Biosciences Inc.
How long has Adele M. Gulfo served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.